Allison M. Andrews
Affiliations: | 2014- | Pathology and Laboratory Medicine | Temple University School of Medicine, Philadelphia, PA, United States |
Google:
"Allison Andrews"Mean distance: 21.33 (cluster 52) | S | N | B | C | P |
Parents
Sign in to add mentor| Kenneth A. Barbee | grad student | 2006-2012 | Drexel | |
| (Shear stress-induced nitric oxide (NO) production: Mechanisms and the inhibitory effect of cholesterol enrichment.) | ||||
| Dov Jaron | grad student | 2006-2012 | Drexel | |
| (Shear stress-induced nitric oxide (NO) production: Mechanisms and the inhibitory effect of cholesterol enrichment.) | ||||
| Servio H. Ramirez | post-doc | 2014- | Temple University School of Medicine | |
| Victor Rizzo | post-doc | 2012-2013 | Temple University | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bullock TA, Galpayage Dona KNU, Hale JF, et al. (2023) Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair. Neuroimmune Pharmacology and Therapeutics. 2: 387-400 |
| Galpayage Dona KNU, Ramirez SH, Andrews AM. (2023) A Next-Generation 3D Tissue-Engineered Model of the Human Brain Microvasculature to Study the Blood-Brain Barrier. Bioengineering (Basel, Switzerland). 10 |
| Ramirez SH, Hale J, McCarthy S, et al. (2023) An engineered AAV capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature. Human Gene Therapy |
| DeOre BJ, Tran KA, Andrews AM, et al. (2021) SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Ramirez SH, Buzhdygan TP, Hale JF, et al. (2021) Correction to: Extracellular Microvesicles Released From Brain Endothelial Cells are Detected in Animal Models Of HIV‑1 Signifying Unresolved Inflammation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Galpayage Dona KNU, Hale JF, Salako T, et al. (2021) The Use of Tissue Engineering to Fabricate Perfusable 3D Brain Microvessels . Frontiers in Physiology. 12: 715431 |
| Ramirez SH, Buzhdygan TP, Hale JF, et al. (2021) Extracellular Microvesicles Released From Brain Endothelial Cells are Detected in Animal Models Of HIV-1 Signifying Unresolved Inflammation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Buzhdygan TP, Rodrigues CR, McGary HM, et al. (2021) The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties. Journal of Neuroinflammation. 18: 63 |
| Wu L, Islam MR, Lee J, et al. (2021) ErbB3 is a critical regulator of cytoskeletal dynamics in brain microvascular endothelial cells: Implications for vascular remodeling and blood-brain-barrier modulation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20984976 |
| Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. (2020) The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiology of Disease. 146: 105131 |